Lester Adaptation of Cardio Metabolic Measurements: An Inpatient Interventional Framework for Women with Mental Illness

M. Godbole, M. Lotfy, L. McGowen
{"title":"Lester Adaptation of Cardio Metabolic Measurements: An Inpatient Interventional Framework for Women with Mental Illness","authors":"M. Godbole, M. Lotfy, L. McGowen","doi":"10.4172/2161-1017.1000264","DOIUrl":null,"url":null,"abstract":"Aims of the study: To assess the prevalence of metabolic syndrome and implement a framework for screening and management of cardio metabolic risks in women on psychiatric in-patient wards. Background: An estimated 29-48% of psychiatric in-patients have metabolic syndrome. Severe mood disorders and psychotic illnesses are independent risk factors. 20-25% of the world’s adult population have metabolic syndrome and they are twice as likely to die from and three times as likely to have a heart attack or stroke compared with people without the syndrome. This study gives an overview of the application of Lester Tool on busy in-patient units and interventional approaches adapted by the team. Method: 46 admissions between April to July 2015 were included in Phase 1. Information on physical health medication and menopausal status was recorded in addition to metabolic syndrome parameters. Data on 47 admissions in Phase 2 between March to May 2016 was obtained. Advice on healthy lifestyle, diet, medication and smoking cessation was offered as routine. Results: Phase 1: Of the total 46 patients, 38 (82.60%) were on antipsychotics, 6 (13.04%) had metabolic syndrome and 14 (30.43%) did not and data was not available on 26 (56.52%). Most frequently missing criteria were waist circumference and triglyceride measurements. Phase 2: Of the total 45 patients, 14 (31.1%) had metabolic syndrome, 12 (26.6%) did not and data was unknown in 13 (28.8%). 2/3rd of admissions were compliant with investigations, as opposed to 1/3rd in Phase 1. 86.6% compliance was achieved in BMI checks. 20% were prescribed anti-hypertensive or anti-diabetic medication during admission and were referred to the dietician and diabetes clinic. Conclusion: Clinical identification and management of metabolic syndrome is essential and preventative measures by referral to specialist services or use of 3DFD model could be implemented. Lester Adaptation has been an effective tool for recording cardio metabolic risks; but in reality an effective interventional process could prove hard to achieve in mental health settings.","PeriodicalId":11670,"journal":{"name":"Endocrinology and Metabolic Syndrome","volume":"23 1","pages":"1-6"},"PeriodicalIF":0.0000,"publicationDate":"2017-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrinology and Metabolic Syndrome","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2161-1017.1000264","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aims of the study: To assess the prevalence of metabolic syndrome and implement a framework for screening and management of cardio metabolic risks in women on psychiatric in-patient wards. Background: An estimated 29-48% of psychiatric in-patients have metabolic syndrome. Severe mood disorders and psychotic illnesses are independent risk factors. 20-25% of the world’s adult population have metabolic syndrome and they are twice as likely to die from and three times as likely to have a heart attack or stroke compared with people without the syndrome. This study gives an overview of the application of Lester Tool on busy in-patient units and interventional approaches adapted by the team. Method: 46 admissions between April to July 2015 were included in Phase 1. Information on physical health medication and menopausal status was recorded in addition to metabolic syndrome parameters. Data on 47 admissions in Phase 2 between March to May 2016 was obtained. Advice on healthy lifestyle, diet, medication and smoking cessation was offered as routine. Results: Phase 1: Of the total 46 patients, 38 (82.60%) were on antipsychotics, 6 (13.04%) had metabolic syndrome and 14 (30.43%) did not and data was not available on 26 (56.52%). Most frequently missing criteria were waist circumference and triglyceride measurements. Phase 2: Of the total 45 patients, 14 (31.1%) had metabolic syndrome, 12 (26.6%) did not and data was unknown in 13 (28.8%). 2/3rd of admissions were compliant with investigations, as opposed to 1/3rd in Phase 1. 86.6% compliance was achieved in BMI checks. 20% were prescribed anti-hypertensive or anti-diabetic medication during admission and were referred to the dietician and diabetes clinic. Conclusion: Clinical identification and management of metabolic syndrome is essential and preventative measures by referral to specialist services or use of 3DFD model could be implemented. Lester Adaptation has been an effective tool for recording cardio metabolic risks; but in reality an effective interventional process could prove hard to achieve in mental health settings.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
莱斯特适应心脏代谢测量:一个住院妇女精神疾病介入框架
研究目的:评估代谢综合征的患病率,并实施筛查和管理精神科住院妇女心血管代谢风险的框架。背景:估计29-48%的精神科住院患者患有代谢综合征。严重的情绪障碍和精神疾病是独立的危险因素。世界上20-25%的成年人患有代谢综合征,与没有代谢综合征的人相比,他们死于代谢综合征的可能性是正常人的两倍,患心脏病或中风的可能性是正常人的三倍。本研究概述了莱斯特工具在繁忙的住院单位和团队采用的介入方法中的应用。方法:选取2015年4月至7月收治的46例患者作为第一期研究对象。除了代谢综合征参数外,还记录了身体健康、药物和更年期状况的信息。获得了2016年3月至5月第二阶段47例入院患者的数据。关于健康的生活方式、饮食、药物治疗和戒烟的建议被作为常规提供。结果:1期:46例患者中,38例(82.60%)患者使用抗精神病药物,6例(13.04%)患者存在代谢综合征,14例(30.43%)患者未出现代谢综合征,26例(56.52%)患者数据无法获得。最常见的缺失标准是腰围和甘油三酯测量。二期:在45例患者中,14例(31.1%)有代谢综合征,12例(26.6%)无代谢综合征,13例(28.8%)数据未知。与第一阶段的1/3相比,2/3的入学符合调查要求。BMI检查依从率达86.6%。20%的患者在入院时服用降压或降糖药物,并转介到营养师和糖尿病诊所。结论:代谢综合征的临床识别和管理是必要的,可采取转诊或使用3DFD模型的预防措施。适应性是记录心脏代谢风险的有效工具;但实际上,在心理健康环境中,可能很难实现有效的干预过程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Short Communication on Human Endocrine System: Structure and Development. A Brief Note on Drug Development Diabetic Nephropathy: A Plant Based Approach Signs and Symptoms of Cushing's Syndrome An Overview of Diabetes Types and Treatments
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1